INS and neurodegenerative disease: Impairments in insulin regulation are associated with obesity, diabetes, cardiovascular disease, and hypertension [23], and abnormalities in neural insulin signaling pathways are associated with various neurodegenerative diseases and deficits in learning and memory [24].